- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 3.85M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.33M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $11.93M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $870K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $4M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $13.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $12.81M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $16.39M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $25.41M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $10.14M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $10.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $47.28M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $50.64M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 3.82K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $16K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $986K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $35.18M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $35.42M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.64M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $654K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$139K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$862K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $4.18M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.39M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $5.57M |